Navigation Links
Lotus Pharmaceuticals Preparing to Apply for National Exchange Listing
Date:10/22/2010

ties: Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus' current drug development is focused on the treatment of cerebro-cardiovascular diseases, asthma and diabetes. Liang Fang sells drugs directly and indirectly through its national sales channels to hospitals, clinics and drug stores in 30 provinces of the PRC.

Information Regarding Forward-Looking StatementsExcept for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product demand, market competition, and risks inherent in our operations. These and other risks are described in our filings with the U.S. Securities and Exchange Commission.Contacts:At the Company:Xing Shen, Ph.D.VP of Corporate DevelopmentLotus Pharmaceuticals, Inc.Ph: 415-690-7688Email: shen@lotuspharma.comWeb: http://www.lotuspharma.comInvestor Relations:Jon CunninghamRedChip Companies, Inc.Tel: +1-800-733-2447, Ext. 107Email: info@redchip.comJing Zhang, ChinaRedChip Beijing Representative OfficeTel: +86 10-8591-0635Web: http://www.RedChip.com
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel
2. Lotus Pharmaceuticals Announces Two Senior Management Appointments
3. Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts
4. Lotus Pharmaceuticals Enter R-Bambuterol(R) Clinical Trial I
5. Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results
6. Lotus Completed R-Bambuterols Pilot Scale Production for Clinical Trials
7. Lotus Pharmaceuticals Terminates SEDA
8. Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
9. Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform
10. Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
11. Lotus Pharmaceuticals Laevo-Bambuterol Received SFDA Approval to Commence Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... NEW YORK , June 19, ... announces that a new market research ... Partnerships, Licensing, Investments ... May 2013 in Pharmaceuticals ... Licensing, Investments and M&A Deals and ...
(Date:6/19/2013)... 19, 2013 A decade-long JDRF-funded study led ... München, Germany , is providing a ... risk of developing type 1 diabetes (T1D), highlighting the ... disease. The study, "Seroconversion to Multiple Islet Autoantibodies and ... today in The Journal of the American Medical ...
(Date:6/19/2013)... June 19, 2013   BioCision , a ... and handling in many areas of medical and ... patents by the U.S. Patent Office that apply ... to standardize sample handling to ensure the consistency ... common laboratory procedures. Patent number ...
Breaking Medicine Technology:Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 2Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 3Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 4Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 5Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 6Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 7Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 8Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 9Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 10Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 11Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 12Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 13New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... - Patient retention and conduct of Phase 3 CAPACITY program remain ... excellent to date -, - ... ... Calif., April 21 InterMune, Inc.,(Nasdaq: ITMN ) today announced that it will initiate ...
... Inc. (OTC Bulletin Board: AIDA) (hereinafter referred to,as ... potential cancer drug,that seeks to trigger cell death ... being developed by Aida,s Shanghai,Qiaer subsidiary, is a ... fragments of Vasostatin, an inhibitor of angiogenesis,and tumor ...
Cached Medicine Technology:InterMune Announces Progress on Pirfenidone in IPF 2InterMune Announces Progress on Pirfenidone in IPF 3InterMune Announces Progress on Pirfenidone in IPF 4Aida Announces New Anti-Cancer Drug Under Development 2
(Date:6/20/2013)... 2013 Rampant staph infections continue to ... this scourge is being successfully deployed by China's military: ... and by touching items that are contaminated such as ... by the San Francisco Chronicle , “It is ... during hospital stays, and at least 90,000 of them ...
(Date:6/20/2013)... During a June 13 panel discussion on health ... Benefit Exchange confirmed the existence of the Federal Data ... consider,” writes panel moderator Steve Davis in a ... and leprechauns.” , “We are the only state to ... live,” Rebecca Pearce told attendees at Gorman Health Group’s ...
(Date:6/20/2013)... NJ (PRWEB) June 20, 2013 As ... is volunteer assistance. Keeping volunteers motivated in a non-profit ... Kars4Kids , a the nation’s leading car donation charity ... network of over 1,000 individuals, has announced the best ... not only physically present, but mentally engaged as well. ...
(Date:6/20/2013)... Handgiftbox.com Mobile, a leading manufacturer and distributor of ... the launch of 16GB version of the Mini Studio ... high-performance, high-quality tablet that is a direct competitor to ... $256 but it will be launched at promotional price ... , The Mini STUDIO is part of the Handgiftbox.com ...
(Date:6/20/2013)... Phoenix, AZ (PRWEB) June 20, 2013 ... used recreational vehicle sales, warns campers that improperly handled food ... consequences. , Now that summertime has arrived, many RV campers ... al fresco. Whether they are eating outdoors at the campground ... food are ever present and should be avoided at all ...
Breaking Medicine News(10 mins):Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 2Health News:Lab Testing Reveals EnviroTextile's Hemp Fabric Stops the Spread of Staph Bacteria 3Health News:Federal Data Services Hub Does Exist, AISHealth.com Blog Post Reports 2Health News:Kars4kids Announces Tips on How to Keep Non-profit Volunteers Engaged, Passionate and Active 2Health News:Android Tablet PC Mini Studio with Android 4.1 with 16GB is Here at $121 Only at Handgiftbox.com 2Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 2Health News:Pedata RV Center Warns Campers of the Dangers of Mishandled Food 3
... 2007)Uninsured patients in publicly funded community health centers face ... a new study finds. Whats more, this is even ... patient does in fact need these services. Conversely, community ... easier time accessing services. , Often times, people ...
... Research here shows that an obscure form of RNA, ... an important role in human cancer. , These ultraconserved ... but a new report in the September issue of the ... case. , The study found that UCRs, like classic ...
... Calif., Sept. 11 Cepheid (Nasdaq:,CPHD) will present ... the St. Regis Hotel, San Francisco, on Sept. ... Chief Financial Officer, John Sluis will present,at 9:30 ... audio webcast of the presentation, along with,accompanying presentation ...
... Jacobs Engineering,Group Inc. (NYSE: JEC ) announced today ... provide owner-engineer support for a new 220-bed,53,000 square meter ... for cancer identification and treatment. Officials did not ... investment cost for the new hospital is over Euro ...
... Industries Corporation (OTC Pink Sheets: CBIU), a leading,company ... new,series of biological nanometer cosmetics products named "U-SOGNO" ... experiments. The,name comes from the Italian word -- ... -- "One,s Dreams Coming True." The new ...
... Availability of Monte Carlo Dose Calculation Software Announced ... European Radiation Oncology Meeting in Barcelona, BARCELONA, Spain, ... global leader in the field of radiosurgery,announced today that ... from the U.S. Food and Drug Administration and is,now ...
Cached Medicine News:Health News:Uninsured community health center patients often have difficulty accessing specialty services 2Health News:Uninsured community health center patients often have difficulty accessing specialty services 3Health News:New class of RNA molecules may be important in human cancer 2Health News:Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference 2Health News:Jacobs Receives Contract for New Hospital Project in Belgium 2Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 2Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 3Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 2Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 3Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 4Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 5
... is a non-invasive massage machine for ... the circulatory system. Extraordinary results are ... action, which combines vertical and parallel ... percussion, gyratory massage, deep tissue mobilization, ...
The Ritter 204 Manual Exam Table. Featuring the latest in design, comfort and functionality in a manual exam table, it truly offers efficient patient care....
... 622 and 623 High-Low Examination Tables deliver the ... you. Many different types of patients can ... how to get on the exam table. Being ... ,can increase a patients comfort during the exam, ...
... MegaPeel microdermabrasion systems offer many features that ... save you time and money. Because our ... easy to use and maintain, you spend ... your microdermabrasion equipment. MegaPeel microdermabrasion systems are ...
Medicine Products: